Bank of Montreal’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.06M Buy
73,820
+2,271
+3% +$125K ﹤0.01% 1156
2025
Q1
$5.06M Buy
71,549
+3,397
+5% +$240K ﹤0.01% 1037
2024
Q4
$4.48M Sell
68,152
-14,519
-18% -$954K ﹤0.01% 1110
2024
Q3
$5.83M Sell
82,671
-168,254
-67% -$11.9M ﹤0.01% 1136
2024
Q2
$21.4M Buy
250,925
+181,935
+264% +$15.5M 0.01% 698
2024
Q1
$6.03M Buy
68,990
+559
+0.8% +$48.8K ﹤0.01% 1030
2023
Q4
$6.7M Sell
68,431
-224,356
-77% -$22M ﹤0.01% 1004
2023
Q3
$26.5M Buy
292,787
+220,464
+305% +$19.9M 0.01% 567
2023
Q2
$6.99M Sell
72,323
-43,507
-38% -$4.21M ﹤0.01% 1036
2023
Q1
$11.3M Buy
115,830
+556
+0.5% +$54.1K ﹤0.01% 822
2022
Q4
$12.1M Buy
115,274
+38,582
+50% +$4.04M 0.01% 785
2022
Q3
$6.6K Sell
76,692
-181,686
-70% -$15.6K ﹤0.01% 1011
2022
Q2
$22.1K Buy
258,378
+27,454
+12% +$2.35K 0.01% 617
2022
Q1
$18.3M Buy
230,924
+75,322
+48% +$5.97M 0.01% 722
2021
Q4
$13.9M Buy
155,602
+11,755
+8% +$1.05M 0.01% 836
2021
Q3
$11.1M Buy
143,847
+9,632
+7% +$741K 0.01% 1122
2021
Q2
$11.2M Sell
134,215
-2,939
-2% -$246K 0.01% 1135
2021
Q1
$10.7M Buy
137,154
+36,883
+37% +$2.89M 0.01% 882
2020
Q4
$8.15M Sell
100,271
-10,029
-9% -$815K 0.01% 983
2020
Q3
$8.33M Buy
110,300
+14,683
+15% +$1.11M 0.01% 846
2020
Q2
$12.1M Buy
95,617
+15,004
+19% +$1.9M 0.01% 685
2020
Q1
$6.94M Sell
80,613
-14,817
-16% -$1.28M 0.01% 782
2019
Q4
$8.07M Sell
95,430
-43,978
-32% -$3.72M 0.01% 960
2019
Q3
$9.4M Buy
139,408
+54,828
+65% +$3.7M 0.01% 799
2019
Q2
$7.25M Sell
84,580
-20,434
-19% -$1.75M 0.01% 917
2019
Q1
$9.33M Sell
105,014
-4,343
-4% -$386K 0.01% 805
2018
Q4
$9.31M Sell
109,357
-710
-0.6% -$60.5K 0.01% 754
2018
Q3
$10.7M Sell
110,067
-4,686
-4% -$454K 0.01% 818
2018
Q2
$10.8M Buy
114,753
+1,150
+1% +$108K 0.01% 807
2018
Q1
$9.21M Buy
113,603
+4,469
+4% +$362K 0.01% 840
2017
Q4
$9.73M Buy
109,134
+6,802
+7% +$607K 0.01% 823
2017
Q3
$9.52M Buy
102,332
+7,749
+8% +$721K 0.01% 839
2017
Q2
$8.59M Sell
94,583
-49,330
-34% -$4.48M 0.01% 871
2017
Q1
$12.6M Buy
143,913
+56,388
+64% +$4.95M 0.01% 697
2016
Q4
$7.49M Sell
87,525
-2,778
-3% -$238K 0.01% 850
2016
Q3
$8.36M Sell
90,303
-3,987
-4% -$369K 0.01% 843
2016
Q2
$7.34M Sell
94,290
-196
-0.2% -$15.3K 0.01% 890
2016
Q1
$7.79M Buy
94,486
+13,396
+17% +$1.1M 0.01% 794
2015
Q4
$8.5M Buy
81,090
+7,448
+10% +$780K 0.01% 758
2015
Q3
$7.76M Sell
73,642
-166,069
-69% -$17.5M 0.01% 770
2015
Q2
$32.8M Buy
239,711
+197,858
+473% +$27.1M 0.04% 364
2015
Q1
$5.22M Sell
41,853
-4,175
-9% -$520K 0.01% 963
2014
Q4
$4.16M Buy
46,028
+1,397
+3% +$126K ﹤0.01% 968
2014
Q3
$3.22M Buy
44,631
+13,356
+43% +$964K ﹤0.01% 1054
2014
Q2
$1.95M Buy
31,275
+3,951
+14% +$246K ﹤0.01% 1205
2014
Q1
$1.86M Buy
27,324
+1,948
+8% +$133K ﹤0.01% 1087
2013
Q4
$1.78M Buy
25,376
+471
+2% +$33.1K ﹤0.01% 1076
2013
Q3
$1.8M Sell
24,905
-804
-3% -$58K ﹤0.01% 1027
2013
Q2
$1.43M Buy
+25,709
New +$1.43M ﹤0.01% 1048